Symbols / GANX $1.90 +2.70% Gain Therapeutics, Inc.

Healthcare • Biotechnology • United States • NGM
GANX Chart
About

No company description available for this symbol.

Fundamentals
Scroll to Statements
Sector Healthcare Industry Biotechnology Market Cap 80.73M
Enterprise Value 58.04M Income -20.16M Sales
Book/sh 0.44 Cash/sh 0.49 Dividend Yield
Payout 0.00% Employees IPO
P/E Forward P/E -3.05 PEG
P/S P/B 4.31 P/C
EV/EBITDA -3.11 EV/Sales Quick Ratio 6.46
Current Ratio 6.63 Debt/Eq 3.94 LT Debt/Eq
EPS (ttm) -0.61 EPS next Y -0.62 EPS Growth
Revenue Growth Earnings 2026-03-26 16:00 ROA -67.00%
ROE -155.66% ROIC Gross Margin 0.00%
Oper. Margin 0.00% Profit Margin 0.00% Shs Outstand 42.49M
Shs Float 40.90M Short Float 6.92% Short Ratio 3.55
Short Interest 52W High 4.34 52W Low 1.41
Beta 0.11 Avg Volume 812.28K Volume 143.33K
Target Price $7.60 Recom Strong_buy Prev Close $1.85
Price $1.90 Change 2.70%
Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
Mean price target
2. Current target
Latest analyst target
3. DCF / Fair value
$-4.45
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
Low
High
Mean

No recent news from Yahoo. Try the RSS feed for latest GANX news.

Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2024-08-09 ISLAM KHALID Officer and Director 50,000 $1.00 $49,940
2024-08-09 MACK GENE C Chief Executive Officer 14,400 $1.01 $14,544
2024-07-01 RICHMAN ERIC I. Director 17,000 $1.21 $20,670
Financials

No financial statements available. Data is sourced from Yahoo Finance and cached; historical storage may be added later.

SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category